Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study - Ku, Geoffrey; Haag, Georg Martin; Park, H.; Lam, V. K.; George, T. J.; Kim, S. S.; Gutierrez, M.; Shankaran, V.; Stein, S.; Denlinger, C. S.; Elimova, E.; Nagrial, A.; et al. (ESMO open, 2025)
Gesehen am 15.07.2025